Physician Assistant, Medical · Denville, NJ
NPI
1427480292
Since 2013
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
23 Pocono Rd, Suite 100
Denville, NJ, 07834
Phone (973) 316-1701
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.8M
972 prescriptions
Company payments, 2025
$1,397
From 27 companies
Medicare prescription drug claims, 2024
In 2024, the drug Kate F McCooey prescribed most often to Medicare patients was Procrit (Epoetin Alfa), with 84 prescriptions and refills. In total Kate F McCooey wrote 972 Medicare prescriptions that cost $3.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-08-05.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Procrit Epoetin Alfa | 84 | 84 | 38 | $268K |
| Anastrozole Generic | 63 | 157 | 25 | $1,222 |
| Neulasta Onpro Pegfilgrastim | 59 | 59 | 14 | $368K |
| Eliquis Apixaban | 56 | 66 | 15 | $39K |
| Xarelto Rivaroxaban | 48 | 84 | 17 | $47K |
| Hydroxyurea Generic | 38 | 72 | 15 | $791 |
| Letrozole Generic | 25 | 55 | Under 11 | $568 |
| Prochlorperazine Maleate Generic | 24 | 24 | 18 | $314 |
| Palonosetron Hcl Generic | 22 | 22 | Under 11 | $3,163 |
| Lupron Depot Leuprolide Acetate | 21 | 35 | Under 11 | $69K |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 21 | 21 | Under 11 | $144K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 19 | 19 | 11 | $359 |
| Jakafi Ruxolitinib Phosphate | 19 | 19 | Under 11 | $316K |
| Neulasta Pegfilgrastim | 19 | 19 | Under 11 | $151K |
| Brukinsa Zanubrutinib | 18 | 18 | Under 11 | $249K |
Brand drugs: 507 claims; generic drugs: 465 claims; opioid claims: 42.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kate F McCooey $1,397 ($1,397 in general payments such as food, travel and fees) from 27 companies. The largest payer was Daiichi Sankyo Inc. with $208.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 11 | $208 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $165 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $147 |
| GlaxoSmithKline, LLC. GSK | 6 | $117 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $97.34 |
| Janssen Biotech, Inc. JNJ | 4 | $71.58 |
| Incyte Corporation INCY | 3 | $56.72 |
| Blueprint Medicines Corporation SNY | 3 | $56.08 |
| Celgene Corporation BMY | 3 | $48.35 |
| Adaptive Biotechnologies Corporation ADPT | 2 | $41.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.